Psychedelic Stock Filament Health Jumps On Announcing First Psilocin Clinical Trial
Psychedelic drug discovery company Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) obtained FDA approval to start the first clinical trial using naturally-sourced psychedelic substances.
